By Counterforce Health Team in Revcovi (elapegademase) —

How to Get Revcovi (Elapegademase) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization Guide

Answer Box: Getting Revcovi Covered by BCBS in New Jersey

Revcovi (elapegademase) requires prior authorization from Horizon Blue Cross Blue Shield of New Jersey. Your fastest path to approval: (1) Confirm ADA-SCID diagnosis with enzyme/genetic testing, (2) Have your immunologist submit the specialty medication PA form through Horizon's provider portal with complete clinical documentation, and (3) Use CVS Caremark Specialty or another in-network specialty pharmacy. If denied, New Jersey's IHCAP external review through Maximus Federal Services gives you strong appeal rights. Start by calling the number on your insurance card to verify your specific plan requirements.

Table of Contents

  1. Verify Your Plan and Find the Right Forms
  2. Prior Authorization Forms and Requirements
  3. Submission Portals and Upload Process
  4. Specialty Pharmacy Network Requirements
  5. Common Denial Reasons and How to Fix Them
  6. Appeals Process: Internal and External Reviews
  7. New Jersey IHCAP External Review Guide
  8. Support Lines and Contacts
  9. FAQ: Your Most Common Questions

Verify Your Plan and Find the Right Forms

Before starting your prior authorization request, confirm you have the right Blue Cross Blue Shield plan. In New Jersey, Horizon Blue Cross Blue Shield is the largest BCBS carrier, covering about 39% of the market. However, some employer groups may use other BCBS subsidiaries or self-funded arrangements.

Tip: Look at your insurance card. If it says "Horizon BCBSNJ" or "Horizon Blue Cross Blue Shield of New Jersey," you're in the right place. Self-funded employer plans follow different federal appeal rules.

Key Information to Gather:

  • Your member ID and group number
  • Prescribing physician's NPI and contact information
  • Complete diagnosis documentation for ADA-SCID
  • Previous treatment history and failures
  • Current lab values and genetic test results

Prior Authorization Forms and Requirements

Revcovi requires prior authorization for all Horizon BCBSNJ lines of business. The specific requirements include:

Medical Necessity Documentation Checklist

✅ Definitive ADA-SCID diagnosis with supporting evidence:

  • Enzyme activity assay showing absent/extremely low ADA activity (<1% of normal)
  • Genetic testing confirming biallelic pathogenic mutations in ADA gene
  • Clinical evidence of immunodeficiency (recurrent infections, lymphopenia)

✅ Specialist management requirement:

  • Treatment under board-certified immunologist or hematologist
  • Specialist attestation letter explaining medical necessity
  • Documentation of why curative options (bone marrow transplant, gene therapy) aren't appropriate

✅ Treatment history documentation:

  • Previous therapy trials and outcomes
  • Contraindications to alternative treatments
  • Current clinical status and treatment goals

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required before dispensing Horizon provider portal Horizon BCBSNJ Policy
Specialist Care Immunologist/hematologist management Provider network directory Horizon Provider Directory
Specialty Pharmacy Must use in-network specialty pharmacy Member portal pharmacy locator Horizon Specialty Pharmacy
Appeals Deadline 180 days for commercial plans Plan documents NJ DOBI Appeals Guide

Submission Portals and Upload Process

Provider Portal Submission

Primary method: Submit through the Horizon BCBSNJ provider portal using the specialty medication prior authorization form. The portal allows you to:

  • Upload supporting clinical documentation
  • Track submission status
  • Receive real-time updates on approval decisions
  • Access required forms and policy updates

Alternative Submission Methods

If portal submission isn't available:

Fax submissions: Contact Horizon's pharmacy services at the number on the member's insurance card for the current fax number. Common specialty pharmacy fax numbers include:

  • CVS Caremark Specialty: 1-800-323-2445
  • Walgreens Specialty: 1-877-231-8302
Important: Always verify current fax numbers before submitting, as they change frequently.

Specialty Pharmacy Network Requirements

Revcovi must be dispensed through Horizon's in-network specialty pharmacies. Attempting to fill at retail pharmacies will result in claim rejection.

In-Network Specialty Pharmacies

  • CVS Caremark Specialty Pharmacy: 1-800-237-2767
  • Walgreens Specialty Pharmacy: 866-823-9575
  • Schraft's 2.0: 855-724-7238
Note: Some employer groups restrict specialty drugs exclusively to Accredo. Check your specific plan benefits or call the member services number on your insurance card.

Patient Enrollment Process

  1. Provider submits prescription to designated specialty pharmacy
  2. Pharmacy initiates benefits verification and prior authorization
  3. Patient enrollment in pharmacy support programs
  4. Medication dispensing with home delivery or provider office shipment
  5. Ongoing support including adherence monitoring and injection training

Common Denial Reasons and How to Fix Them

Denial Reason How to Overturn Required Documentation
Missing ADA-SCID confirmation Submit complete diagnostic workup Enzyme assay results, genetic testing, clinical notes
Lack of specialist management Provide immunologist attestation Board certification, treatment plan, monitoring schedule
Insufficient prior therapy documentation Document treatment history Previous medication trials, outcomes, contraindications
Dosing frequency concerns Justify dosing regimen Weight-based calculations, FDA labeling, clinical guidelines
Site-of-care issues Clarify administration setting Provider qualifications, safety protocols, monitoring plan

Clinician Corner: Medical Necessity Letter Essentials

Your medical necessity letter should address:

  1. Patient's clinical presentation with ADA-SCID diagnosis
  2. Diagnostic confirmation (enzyme activity, genetic testing)
  3. Previous treatment attempts and why they failed or aren't suitable
  4. Clinical rationale for Revcovi based on FDA labeling and guidelines
  5. Monitoring plan and expected outcomes
  6. Contraindications to alternative therapies

Include references to FDA labeling and relevant immunodeficiency treatment guidelines.

Appeals Process: Internal and External Reviews

Internal Appeal Timeline

Step 1: Initial Review (15-30 days)

  • Submit appeal through Horizon provider portal
  • Include all supporting documentation
  • Request expedited review if clinically urgent

Step 2: Second-Level Review

  • Peer-to-peer review with Horizon medical director
  • Additional clinical documentation may be requested
  • Final internal decision typically within 60 days

When Internal Appeals Are Exhausted

If Horizon upholds the denial after internal appeals, you have the right to external review through New Jersey's Independent Health Care Appeals Program (IHCAP).

New Jersey IHCAP External Review Guide

New Jersey offers one of the most comprehensive external review programs in the country through Maximus Federal Services.

Eligibility Requirements

  • Completed Horizon's internal appeal process
  • Denial based on medical necessity, experimental/investigational determination
  • Fully insured New Jersey plan (not self-funded employer plans)
  • Filed within 4 months of final internal denial

How to Submit Your External Appeal

Online: Register at njihcap.maximus.com

Fax: (585) 425-5296

Mail:

Maximus
Attn: State Appeals/NJ IHCAP
3750 Monroe Avenue, Suite 705
Pittsford, NY 14534

Required Documents

  • Completed external appeal application
  • Copies of all internal denial letters
  • Medical records supporting the request
  • Provider's detailed clinical justification
From our advocates: We've seen external appeals succeed when families include a comprehensive timeline of their child's infections and hospitalizations alongside the genetic testing results. The independent medical reviewers need to understand both the laboratory confirmation of ADA-SCID and the real-world clinical impact. This approach helped one family get coverage after two internal denials.

External Review Timeline

  • Preliminary review: 5 business days to confirm eligibility
  • Full review: Up to 45 days for standard appeals
  • Expedited review: Available if delay would cause serious harm
  • Cost: Free to patients (insurers pay all fees)

Success rates: External appeals nationwide favor consumers in approximately 50% of cases, with higher success rates for rare disease treatments with strong clinical evidence.

Support Lines and Contacts

Member Services

  • Horizon BCBSNJ Member Services: Number on back of insurance card
  • Pharmacy Benefits: Available through member portal or main member services line

Provider Support

  • Provider Services: Available through Horizon provider portal
  • Clinical Pharmacy: For medical necessity questions and peer-to-peer reviews

New Jersey State Resources

  • IHCAP Hotline: 888-393-1062
  • NJ Department of Banking and Insurance: 1-800-446-7467
  • Consumer Assistance: [email protected]

Manufacturer Support

  • Leadiant Biosciences: Contact through healthcare provider for patient assistance programs
  • Revcovi Support: Available through specialty pharmacy network

FAQ: Your Most Common Questions

Q: How long does Horizon BCBS prior authorization take for Revcovi? A: Standard prior authorization decisions are typically made within 15-30 days. Expedited reviews for urgent cases can be completed in 72 hours.

Q: What if Revcovi is not on Horizon's formulary? A: You can request a formulary exception by demonstrating medical necessity and providing clinical justification for why preferred alternatives aren't appropriate.

Q: Can I get an expedited appeal if my child needs Revcovi urgently? A: Yes. Both Horizon's internal appeals and New Jersey's IHCAP external review offer expedited processes when delays could cause serious harm to health.

Q: Does step therapy apply to Revcovi for ADA-SCID? A: Step therapy requirements vary by plan, but for rare diseases like ADA-SCID with limited treatment options, exceptions are often granted with proper clinical documentation.

Q: What happens if I'm denied coverage and can't afford Revcovi? A: Contact your specialty pharmacy about manufacturer patient assistance programs, and consider filing an external appeal through IHCAP. The manufacturer may provide temporary supply during appeals.

Q: Can my doctor file the external appeal for me? A: Yes, providers can file external appeals on behalf of patients with written consent. This is often helpful for complex rare disease cases.

Getting Additional Help

If you're struggling to navigate the prior authorization process, Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to create point-by-point rebuttals that align with your insurer's specific requirements.

For complex cases involving rare diseases like ADA-SCID, having expert support can make the difference between approval and denial. Counterforce Health's system pulls the right clinical evidence and weaves it into appeals that meet procedural requirements while tracking deadlines and required documentation.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice and should not replace consultation with your healthcare provider. Insurance policies and procedures change frequently; always verify current requirements with your specific plan. For personalized assistance with your coverage situation, consult with your healthcare team or a qualified patient advocate.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.